colorectal adenomas
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18-75 years old, regardless of gender; 76-85 years old will be enrolled as appropriate according to the general condition of the subject. 2) People undergoing colonoscopy screening or physical examination 3) Signed informed consent
Exclusion criteria
Exclusion criteria: 1) Therapeutic colonoscopy patients with follow-up or confirmed polyps after polypectomy 2) Highly suspected or diagnosed colorectal cancer 3) Alarming symptoms or signs (blood in stool, dark stool, unexplained anemia and weight loss, abdominal mass, Positive rectal examination) 4) Pregnant or lactating women 5) Gastrointestinal obstruction 6) Inflammatory bowel disease, colon polyposis and serrated polyp syndrome. 7) People who have taken anticoagulants such as aspirin or warfarin within 7 days before the colonoscopy, or people with coagulation abnormalities. Those who are taking anticoagulants such as aspirin or warfarin within 7 days prior to the colonoscopy or have abnormal blood clotting 8) Participating in other clinical observation trials or participating in other clinical trials within 60 days. 9) Failure of insertion of the scope for any reason (obstruction of the scope, inability of the patient to tolerate the examination) or the colonoscope does not reach the cecum 10) Use of bowel preparation medications not recommended by guidelines such as magnesium sulfate, senna, etc. 11) Missing information on the CRF table Translated with www.DeepL.com/Translator (free version)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoma detection rate; | — |
Countries
China
Contacts
Shandong Second Provincial General Hospital